Taipei Exchange - Delayed Quote TWD
Allied Biotech Corporation (1780.TWO)
17.15
+0.45
+(2.69%)
At close: 2:59:21 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
806,917
806,917
720,431
716,746
676,757
Cost of Revenue
548,534
548,534
473,992
445,700
418,707
Gross Profit
258,383
258,383
246,439
271,046
258,050
Operating Expense
170,268
170,268
157,725
169,264
146,384
Operating Income
88,115
88,115
88,714
101,782
111,666
Net Non Operating Interest Income Expense
10,709
10,709
2,671
-6,449
-9,600
Pretax Income
130,035
130,035
122,384
185,035
17,579
Tax Provision
29,096
29,096
24,972
38,294
4,537
Net Income Common Stockholders
100,939
100,939
97,412
146,741
13,042
Diluted NI Available to Com Stockholders
100,939
100,939
97,412
146,741
13,042
Basic EPS
1.05
--
1.02
1.54
0.14
Diluted EPS
1.05
--
1.01
1.53
0.14
Basic Average Shares
96,132.38
--
95,501.96
95,380
95,334
Diluted Average Shares
96,132.38
--
96,447.53
95,780
95,367
Total Expenses
718,802
718,802
631,717
614,964
565,091
Net Income from Continuing & Discontinued Operation
100,939
100,939
97,412
146,741
13,042
Normalized Income
100,939
100,939
97,412
148,329.47
13,042
Interest Income
24,665
24,665
15,628
5,303
1,646
Interest Expense
13,956
13,956
12,957
11,752
11,246
Net Interest Income
10,709
10,709
2,671
-6,449
-9,600
EBIT
143,991
143,991
135,341
196,787
28,825
EBITDA
205,934
205,934
204,792
268,543
94,064
Reconciled Cost of Revenue
548,534
548,534
473,992
445,700
418,707
Reconciled Depreciation
61,943
61,943
69,451
71,756
65,239
Net Income from Continuing Operation Net Minority Interest
100,939
100,939
97,412
146,741
13,042
Total Unusual Items Excluding Goodwill
--
--
--
-2,003
--
Total Unusual Items
--
--
--
-2,003
--
Normalized EBITDA
205,934
205,934
204,792
270,546
94,064
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
--
--
--
-414.53
--
12/31/2021 - 6/20/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4117.TWO General Biologicals Corporation
14.25
+1.79%
6467.TWO TAHO Pharma
56.50
+3.29%
4166.TWO Orient Pharma Co., Ltd.
30.35
+0.83%
4172.TWO InnoPharmax Inc.
15.75
+0.32%
6539.TWO DV Biomed Co., Ltd.
69.90
-6.68%
6817.TWO Winston Medical Supply Co., Ltd.
96.50
+2.33%
6677.TWO Anxo Pharmaceutical Co., Ltd.
17.90
+1.99%
6483.TWO Original BioMedicals Co., Ltd.
12.40
+2.90%
6621.TWO UniPharma Co., Ltd.
15.55
-2.51%
4132.TWO Golden Biotechnology Corporation
15.00
-2.91%